在局部晚期胰腺癌中比较GOO的息方法:系统性审查和元分析.
Asad Gul Rao1, Muhammad Ahmad Nadeem2, Abdul Rafeh Awan3
1Dow University of Health Sciences, Karachi, Pakistan.
Journal of surgical oncology
|November 16, 2025
概括
对于晚期胰腺癌的胃出口阻塞,内镜支架提供更快的恢复,但需要更多的程序. 胃口结节术更耐用,而EUS引导的胃口结节术显示出有希望的结果,但在这种特定的癌症中需要更多的研究.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 干预性内镜检查是干预性的内镜检查.
背景情况:
- 胃出口阻塞 (GOO) 是局部晚期胰腺癌 (LAPC) 的常见并发症.
- 管理选项包括内镜十二指肠支架 (EDS),胃肠口 (GJ) 和EUS导向胃肠口 (EUS-GE).
- 在LAPC中对GOO的最佳管理策略仍在讨论中.
研究的目的:
- 为了比较EDS,GJ和EUS-GE在LAPC管理GOO的有效性和结果.
- 系统地审查关于这些干预措施的现有文献,以恶性GOO为背景,重点是LAPC.
主要方法:
- 对涉及LAPC患者接受EDS或GJ的研究进行了元分析.
- 对评估恶性GOO的EUS-GE研究进行了系统性审查.
- 评估的结果包括成功率,再干预率,恢复时间和化疗启用.
主要成果:
- 在LAPC患者中,EDS促进了更快的康复和化疗启动,但与更高的再干预率有关.
- 在管理GOO时,GJ表现出更大的耐用性.
- 在恶性GOO中,EUS-GE显示出高的成功率和低的再干预率,但LAPC特定数据有限.
结论:
- 对于LAPC中GOO的每项干预都有明显的优点和缺点.
- EDS提供了速度,GJ提供了耐用性,EUS-GE显示了高效率与低重复干预的潜力.
- 进一步的比较研究至关重要,以指导LAPC中GOO的个性化治疗决策.
更多相关视频
03:55Laparoscopic Posterior Radical Antegrade Modular Pancreatosplenectomy for Distal Pancreatic Carcinoma
Published on: December 29, 2023
986
13:56Robot Assisted Distal Pancreatectomy with Celiac Axis Resection DP-CAR for Pancreatic Cancer: Surgical Planning and Technique
Published on: August 14, 2021
7.1K
相关概念视频
Cancer Survival Analysis
624
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
624
Chronic Pancreatitis II: Collaborative Care
282
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
282
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
